Read previewWith weight-loss drugs like WeGovy and Ozempic dominating many of today's consumer healthcare conversations, there's a mounting concern for a particularly vulnerable group: children. In January 2023, the American Academy of Pediatrics (AAP) recommended that healthcare providers offer weight-loss medications, in addition to lifestyle adjustments, to treat obesity in children 12 and older. And in addition, there was limited evidence on weight loss maintenance after medications were discontinued in children," Nicholson said. These injectable drugs have proven successful as weight-loss interventions for adults with obesity, early research shows. Nicholson said clinicians have used lifestyle interventions, like nutrition and exercise plans, to help children with obesity lose weight and reduce risk factors like hypertension, diabetes, and liver disease.

---

Persons: —, Eli Lilly, Hilary Brueck, Wanda Nicholson, Nicholson, Amanda Staiano, Staino Organizations: Service, Pharmaceutical, Novo Nordisk, Business, American Academy of Pediatrics, US Preventive Services, Force, George Washington University School of Public Health, FDA, Pennington Biomedical Research, of Louisiana State University Locations: Pennington